Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Phase III Study to Assess the Long Term Safety Profile of GW433908 Containing Regimens in HIV-1 Infected Subjects

NCT00296504 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT00296504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00296504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Phase III Study to Assess the Long Term Safety Profile of GW433908 Containing Regimens in HIV-1 Infected Subjects
Lead sponsor
ViiV Healthcare
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2001
Completion date
October 31, 2010
Enrollment
753 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

infection, human immunodeficiency virus